Search

everythinglearnresearchcommunity

for

Search:↓

Advanced nanocarrier and microneedle drug delivery methods are more effective, safer, and less invasive for treating skin diseases.

Immune cell-targeting biologics show potential for treating alopecia areata but need better-targeted therapies.

Proteasome inhibitors are promising treatments for various cancers, autoimmune diseases, and other conditions.

Rational design strategies are crucial for developing effective nanozymes for anti-inflammatory uses.

Nanoparticle-based dressings and theranostic innovations improve chronic wound care by effectively targeting biofilms and offering precise treatment.

Using protein degradation to fight cancer drug resistance shows promise but needs more precise targeting and fewer side effects.

Drug repositioning offers a cost-effective, lower-risk way to treat diseases and pandemics like COVID-19.

The document concludes that computational methods using networks and various data can improve the process of finding new uses for existing drugs.

Small molecule drugs show promise for advancing regenerative medicine but still face development challenges.

Androgenetic alopecia treatments are becoming more personalized and include new therapies like topical antiandrogens and regenerative strategies.

Cell therapy is advancing with stem cell transplants and genetically modified cells improving treatment for diseases like cancer and autoimmune disorders.

Researchers identified five new potential targets for leishmaniasis treatment, suggesting repurposing existing drugs could be effective.

New treatments for a type of skin cancer show promise but have side effects and may work better with other therapies.

Ultrasound can improve targeted drug delivery, making treatments more effective with fewer side effects.

Targeted drug delivery to pancreatic beta-cells can improve type 2 diabetes treatment.

Smart biomaterials and dressings show promise in treating chronic skin diseases by improving drug delivery and minimizing side effects.

Non-biologic immunosuppressive drugs are crucial for treating autoimmune and chronic inflammatory skin diseases.

Improving topical drug delivery involves overcoming skin barriers and using personalized dosing to enhance effectiveness.

Repurposing existing drugs can quickly and cheaply find new treatments for diseases.

Thiopurines help treat IBD but require genetic testing to avoid side effects.

Drug repurposing finds new uses for existing drugs, saving time and money.

Biomimetic synthetic vesicles could improve precision medicine by combining natural and synthetic benefits.

New cancer treatments aim to reduce side effects and improve effectiveness.

Smart nano-PROTACs improve cancer treatment by targeting proteins more precisely and reducing side effects.

Repurposing existing drugs can quickly and cheaply find new treatments.

Repurposing existing drugs can quickly and cheaply find new treatments for unmet medical needs.

Targeting mitochondria can improve skin healing and rejuvenation.

Repurposing existing drugs for COVID-19 shows promise but requires more research to confirm effectiveness.

Adding a second method to PROTACs could improve cancer treatment.